Global Intrauterine Devices 麻豆原创 Research Report 2025

Publication ID:

PB501256637

Publication Date:

January 16, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Intrauterine Devices was valued at US$ 2160 million in the year 2024 and is projected to reach a revised size of US$ 2527 million by 2031, growing at a CAGR of 2.3% during the forecast period.
An intrauterine device (IUD) is a small contraceptive device that is put into the uterus (womb) to prevent pregnancy. The 2 types available in Australia are the copper IUD and the hormonal IUD (MirenaTM). The copper IUD is designed to stay in place for up to 10 years and the hormonal IUD (Mirena) for 5 years. Both can easily be removed sooner, if needed.
Global core intrauterine devices manufacturers include Qualitrol, Mitsubishi Electric and Eaton etc. The top 1 company hold a share about 56%. North America is the largest market, with a share about 65%, followed by Europe and Asia Pacific with the share about 24% and 8%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intrauterine Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intrauterine Devices.
The Intrauterine Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intrauterine Devices market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intrauterine Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
By Company
Bayer
Merck
Teva Pharmaceutical
Allergan
HRA Pharma
Eurogine
Yantai JiShengYaoXie
TianYi
SMB Corporation
Shenyang Liren
H & J Medical
Cooper Companies
AbbVie Allergan
Segment by Type
Hormonal IUD
Copper IUD
Segment by End User
Age 20-24
Age 25-34
Age 35-44
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intrauterine Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intrauterine Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Intrauterine Devices 麻豆原创 Overview
1.1 Product Definition
1.2 Intrauterine Devices by Type
1.2.1 Global Intrauterine Devices 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Hormonal IUD
1.2.3 Copper IUD
1.3 Intrauterine Devices by End User
1.3.1 Global Intrauterine Devices 麻豆原创 Value by End User (2024 VS 2031)
1.3.2 Age 20-24
1.3.3 Age 25-34
1.3.4 Age 35-44
1.3.5 Others
1.4 Global Intrauterine Devices 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Intrauterine Devices Revenue 2020-2031
1.4.2 Global Intrauterine Devices Sales 2020-2031
1.4.3 Global Intrauterine Devices 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intrauterine Devices 麻豆原创 Competition by Manufacturers
2.1 Global Intrauterine Devices Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Intrauterine Devices Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Intrauterine Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intrauterine Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intrauterine Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intrauterine Devices, Product Type & Application
2.7 Global Key Manufacturers of Intrauterine Devices, Date of Enter into This Industry
2.8 Global Intrauterine Devices 麻豆原创 Competitive Situation and Trends
2.8.1 Global Intrauterine Devices 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Intrauterine Devices Players 麻豆原创 Share by Revenue
2.8.3 Global Intrauterine Devices 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intrauterine Devices 麻豆原创 Scenario by Region
3.1 Global Intrauterine Devices 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intrauterine Devices Sales by Region: 2020-2031
3.2.1 Global Intrauterine Devices Sales by Region: 2020-2025
3.2.2 Global Intrauterine Devices Sales by Region: 2026-2031
3.3 Global Intrauterine Devices Revenue by Region: 2020-2031
3.3.1 Global Intrauterine Devices Revenue by Region: 2020-2025
3.3.2 Global Intrauterine Devices Revenue by Region: 2026-2031
3.4 North America Intrauterine Devices 麻豆原创 Facts & Figures by Country
3.4.1 North America Intrauterine Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intrauterine Devices Sales by Country (2020-2031)
3.4.3 North America Intrauterine Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intrauterine Devices 麻豆原创 Facts & Figures by Country
3.5.1 Europe Intrauterine Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intrauterine Devices Sales by Country (2020-2031)
3.5.3 Europe Intrauterine Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intrauterine Devices 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Intrauterine Devices 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intrauterine Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Intrauterine Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intrauterine Devices 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Intrauterine Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intrauterine Devices Sales by Country (2020-2031)
3.7.3 Latin America Intrauterine Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intrauterine Devices 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Intrauterine Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intrauterine Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intrauterine Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intrauterine Devices Sales by Type (2020-2031)
4.1.1 Global Intrauterine Devices Sales by Type (2020-2025)
4.1.2 Global Intrauterine Devices Sales by Type (2026-2031)
4.1.3 Global Intrauterine Devices Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Intrauterine Devices Revenue by Type (2020-2031)
4.2.1 Global Intrauterine Devices Revenue by Type (2020-2025)
4.2.2 Global Intrauterine Devices Revenue by Type (2026-2031)
4.2.3 Global Intrauterine Devices Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Intrauterine Devices Price by Type (2020-2031)
5 Segment by End User
5.1 Global Intrauterine Devices Sales by End User (2020-2031)
5.1.1 Global Intrauterine Devices Sales by End User (2020-2025)
5.1.2 Global Intrauterine Devices Sales by End User (2026-2031)
5.1.3 Global Intrauterine Devices Sales 麻豆原创 Share by End User (2020-2031)
5.2 Global Intrauterine Devices Revenue by End User (2020-2031)
5.2.1 Global Intrauterine Devices Revenue by End User (2020-2025)
5.2.2 Global Intrauterine Devices Revenue by End User (2026-2031)
5.2.3 Global Intrauterine Devices Revenue 麻豆原创 Share by End User (2020-2031)
5.3 Global Intrauterine Devices Price by End User (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Intrauterine Devices Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Intrauterine Devices Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Teva Pharmaceutical
6.3.1 Teva Pharmaceutical Company Information
6.3.2 Teva Pharmaceutical Description and Business Overview
6.3.3 Teva Pharmaceutical Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Pharmaceutical Intrauterine Devices Product Portfolio
6.3.5 Teva Pharmaceutical Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Company Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergan Intrauterine Devices Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 HRA Pharma
6.5.1 HRA Pharma Company Information
6.5.2 HRA Pharma Description and Business Overview
6.5.3 HRA Pharma Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 HRA Pharma Intrauterine Devices Product Portfolio
6.5.5 HRA Pharma Recent Developments/Updates
6.6 Eurogine
6.6.1 Eurogine Company Information
6.6.2 Eurogine Description and Business Overview
6.6.3 Eurogine Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eurogine Intrauterine Devices Product Portfolio
6.6.5 Eurogine Recent Developments/Updates
6.7 Yantai JiShengYaoXie
6.7.1 Yantai JiShengYaoXie Company Information
6.7.2 Yantai JiShengYaoXie Description and Business Overview
6.7.3 Yantai JiShengYaoXie Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Yantai JiShengYaoXie Intrauterine Devices Product Portfolio
6.7.5 Yantai JiShengYaoXie Recent Developments/Updates
6.8 TianYi
6.8.1 TianYi Company Information
6.8.2 TianYi Description and Business Overview
6.8.3 TianYi Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 TianYi Intrauterine Devices Product Portfolio
6.8.5 TianYi Recent Developments/Updates
6.9 SMB Corporation
6.9.1 SMB Corporation Company Information
6.9.2 SMB Corporation Description and Business Overview
6.9.3 SMB Corporation Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 SMB Corporation Intrauterine Devices Product Portfolio
6.9.5 SMB Corporation Recent Developments/Updates
6.10 Shenyang Liren
6.10.1 Shenyang Liren Company Information
6.10.2 Shenyang Liren Description and Business Overview
6.10.3 Shenyang Liren Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shenyang Liren Intrauterine Devices Product Portfolio
6.10.5 Shenyang Liren Recent Developments/Updates
6.11 H & J Medical
6.11.1 H & J Medical Company Information
6.11.2 H & J Medical Description and Business Overview
6.11.3 H & J Medical Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 H & J Medical Intrauterine Devices Product Portfolio
6.11.5 H & J Medical Recent Developments/Updates
6.12 Cooper Companies
6.12.1 Cooper Companies Company Information
6.12.2 Cooper Companies Description and Business Overview
6.12.3 Cooper Companies Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Cooper Companies Intrauterine Devices Product Portfolio
6.12.5 Cooper Companies Recent Developments/Updates
6.13 AbbVie Allergan
6.13.1 AbbVie Allergan Company Information
6.13.2 AbbVie Allergan Description and Business Overview
6.13.3 AbbVie Allergan Intrauterine Devices Sales, Revenue and Gross Margin (2020-2025)
6.13.4 AbbVie Allergan Intrauterine Devices Product Portfolio
6.13.5 AbbVie Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intrauterine Devices Industry Chain Analysis
7.2 Intrauterine Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intrauterine Devices Production Mode & Process Analysis
7.4 Intrauterine Devices Sales and 麻豆原创ing
7.4.1 Intrauterine Devices Sales Channels
7.4.2 Intrauterine Devices Distributors
7.5 Intrauterine Devices Customer Analysis
8 Intrauterine Devices 麻豆原创 Dynamics
8.1 Intrauterine Devices Industry Trends
8.2 Intrauterine Devices 麻豆原创 Drivers
8.3 Intrauterine Devices 麻豆原创 Challenges
8.4 Intrauterine Devices 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bayer
Merck
Teva Pharmaceutical
Allergan
HRA Pharma
Eurogine
Yantai JiShengYaoXie
TianYi
SMB Corporation
Shenyang Liren
H & J Medical
Cooper Companies
AbbVie Allergan

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.